NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022

Featured Updates to the NCCN Guidelines

View More View Less
  • 1 Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;
  • | 2 University of Michigan Rogel Cancer Center;
  • | 3 UCLA Jonsson Comprehensive Cancer Center;
  • | 4 Abramson Cancer Center at the University of Pennsylvania;
  • | 5 UC Davis Comprehensive Cancer Center;
  • | 6 The University of Texas MD Anderson Cancer Center;
  • | 7 The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;
  • | 8 University of Wisconsin Carbone Cancer Center;
  • | 9 Robert H. Lurie Comprehensive Cancer Center of Northwestern University;
  • | 10 St. Jude Children's Research Hospital/The University of Tennessee Health Science Center;
  • | 11 Moffitt Cancer Center;
  • | 12 Fox Chase Cancer Center;
  • | 13 Fred & Pamela Buffett Cancer Center;
  • | 14 UCSF Helen Diller Family Comprehensive Cancer Center;
  • | 15 Massachusetts General Hospital Cancer Center;
  • | 16 Stanford Cancer Institute;
  • | 17 Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;
  • | 18 The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;
  • | 19 Mayo Clinic Cancer Center;
  • | 20 UC San Diego Moores Cancer Center;
  • | 21 Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;
  • | 22 City of Hope National Medical Center;
  • | 23 Huntsman Cancer Institute at the University of Utah;
  • | 24 Roswell Park Comprehensive Cancer Center;
  • | 25 Vanderbilt-Ingram Cancer Center;
  • | 26 Dana-Farber/Brigham and Women's Cancer Center;
  • | 27 University of Colorado Cancer Center;
  • | 28 Yale Cancer Center/Smilow Cancer Hospital;
  • | 29 Duke Cancer Institute;
  • | 30 Memorial Sloan Kettering Cancer Center;
  • | 31 O'Neal Comprehensive Cancer Center at UAB;
  • | 32 UT Southwestern Simmons Comprehensive Cancer Center; and
  • | 33 National Comprehensive Cancer Network.

The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting individuals for screening and provide recommendations for evaluation and follow-up of lung nodules found during initial and subsequent screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.

  • 1.

    Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst 2017;109:djx030.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Office of the Surgeon General; Office on Smoking and Health. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2004.

    • Search Google Scholar
    • Export Citation
  • 3.

    Henley SJ, Thomas CC, Lewis DR, et al. Annual report to the nation on the status of cancer, part II: progress toward Healthy People 2020 objectives for 4 common cancers. Cancer 2020;126:22502266.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 2018;68:3154.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Henley SJ, Ward EM, Scott S, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer 2020;126:22252249.

  • 6.

    Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209249.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Islami F, Ward EM, Sung H, et al. Annual report to the nation on the status of cancer, Part 1: national cancer statistics. J Natl Cancer Inst 2021;113:16481669.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin 2022;72:733.

  • 9.

    SEER*Explorer: an interactive website for SEER cancer statistics [internet]. Surveillance Research Program, National Cancer Institute. Accessed June 15, 2022. Available at: https://seer.cancer.gov/statistics-network/explorer/

    • Search Google Scholar
    • Export Citation
  • 10.

    de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020;382:503513.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395409.

  • 12.

    Aberle DR, Black WC, Church TR, et al. Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol 2019;14:17321742.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Pastorino U, Silva M, Sestini S, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol 2019;30:11621169.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Moyer VA, on behalf of the U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330338.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Detterbeck FC, Mazzone PJ, Naidich DP, et al. Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013;143(5 Suppl):e78S92S.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306:18651873.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Midthun DE. Screening for lung cancer. Clin Chest Med 2011;32:659668.

  • 18.

    Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240265.

  • 19.

    Wood DE. Lung cancer screening: the last 10 years. J Natl Compr Canc Netw 2012;10:13231325.

  • 20.

    Wood DE, Kazerooni EA, Aberle D, et al. NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening. Version 1.2022. Accessed June 15, 2022. To view the most recent version, visit NCCN.org

    • Search Google Scholar
    • Export Citation
  • 21.

    Aberle DR, Berg CD, Black WC, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243253.

  • 22.

    Taylor J, Manos D, Schmidt H, et al. Canadian Association of Radiologists: guide on computed tomography screening for lung cancer. Can Assoc Radiol J 2017;68:334341.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907916.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Field JK, Duffy SW, Baldwin DR, et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess 2016;20:1146.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Field JK, Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161170.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Patz EF Jr, Greco E, Gatsonis C, et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016;17:590599.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Wille MMW, Dirksen A, Ashraf H, et al. Results of the Randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016;193:542551.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:13321341.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:13421350.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Prosch H, Schaefer-Prokop C. Screening for lung cancer. Curr Opin Oncol 2014;26:131137.

  • 31.

    Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920931.

  • 32.

    Horeweg N, van der Aalst CM, Thunnissen E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;187:848854.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    McRonald FE, Yadegarfar G, Baldwin DR, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 2014;7:362371.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Field JK, van Klaveren R, Pedersen JH, et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013;108:280286.

  • 35.

    Zhao YR, Xie X, de Koning HJ, et al. NELSON lung cancer screening study. Cancer Imaging 2011;11:S7984.

  • 36.

    Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177184.

  • 37.

    Nair A, Hansell DM. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol 2011;21:24452454.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868874.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Jonas DE, Reuland DS, Reddy SM, et al. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325:971987.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Wood DE, Kazerooni EA, Baum SL, et al. NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening. Version 1.2020. Accessed June 15, 2022. To view the most recent version, visit NCCN.org

    • Search Google Scholar
    • Export Citation
  • 41.

    Wood DE, Kazerooni EA, Aberle D, et al. NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening. Version 1.2021. Accessed June 15, 2022. To view the most recent version, visit NCCN.org

    • Search Google Scholar
    • Export Citation
  • 42.

    Krist AH, Davidson KW, Mangione CM, et al. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. JAMA 2021;325:962970.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43.

    Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245254.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44.

    Jaklitsch MT, Jacobson FL, Austin JHM, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:3338.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    Berg CD. Formidable challenges ahead for lung cancer screening. Oncology (Williston Park) 2012;26:182, 185.

  • 46.

    Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen 2012;19:154156.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47.

    McKee BJ, Hashim JA, French RJ, et al. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol 2015;12:192197.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Pinsky PF, Kramer BS. Lung cancer risk and demographic characteristics of current 20-29 pack-year smokers: implications for screening. J Natl Cancer Inst 2015;107:djv226.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296301.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round. J Thorac Oncol 2009;4:608614.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51.

    Menezes RJ, Roberts HC, Paul NS, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 2010;67:177183.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52.

    Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259265.

  • 53.

    Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008;178:956961.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54.

    Aldrich MC, Mercaldo SF, Sandler KL, et al. Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers. JAMA Oncol 2019;5:13181324.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55.

    Pasquinelli MM, Tammemägi MC, Kovitz KL, et al. Risk prediction model versus United States Preventive Services Task Force lung cancer screening eligibility criteria: reducing race disparities. J Thorac Oncol 2020;15:17381747.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56.

    Katki HA, Kovalchik SA, Berg CD, et al. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA 2016;315:23002311.

  • 57.

    Pinsky PF, Gierada DS, Hocking W, et al. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 2014;161:627633.

  • 58.

    Kavanagh J, Liu G, Menezes R, et al. Importance of long-term low-dose CT follow-up after negative findings at previous lung cancer screening. Radiology 2018;289:218224.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59.

    Tammemägi MC, Ten Haaf K, Toumazis I, et al. Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: a secondary analysis of data from the National Lung Screening Trial. JAMA Netw Open 2019;2:e190204.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60.

    de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311320.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61.

    Han SS, Ten Haaf K, Hazelton WD, et al. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer 2017;140:24362443.

  • 62.

    Miller DL, Mayfield WR, Luu TD, et al. Community-based multidisciplinary computed tomography screening program improves lung cancer survival. Ann Thorac Surg 2016;101:18641869.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63.

    Li K, Hüsing A, Sookthai D, et al. Selecting high-risk individuals for lung cancer screening: a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res (Phila) 2015;8:777785.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 64.

    McKee BJ, Regis SM, McKee AB, et al. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol 2016;13(2 Suppl):R2529.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 65.

    Tindle HA, Stevenson Duncan M, Greevy RA, et al. Lifetime smoking history and risk of lung cancer: results from the Framingham Heart Study. J Natl Cancer Inst 2018;110:12011207.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66.

    Ebbert JO, Yang P, Vachon CM, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003;21:921926.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Yang P, Wang Y, Wampfler JA, et al. Trends in subpopulations at high risk for lung cancer. J Thorac Oncol 2016;11:194202.

  • 68.

    Patz EF Jr, Pinsky P, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269274.

  • 69.

    Reich JM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax 2008;63:377383.

  • 70.

    Black WC. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 2007;110:23702384.

  • 71.

    Kazerooni EA, Armstrong MR, Amorosa JK, et al. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol 2016;13(2 Suppl):R3034.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72.

    Wiener RS, Gould MK, Arenberg DA, et al. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med 2015;192: 881891.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 73.

    Mazzone P, Powell CA, Arenberg D, et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society policy statement. Chest 2015;147:295303.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74.

    Davis AM, Cifu AS. Lung cancer screening. JAMA 2014;312:12481249.

  • 75.

    Fintelmann FJ, Bernheim A, Digumarthy SR, et al. The 10 pillars of lung cancer screening: rationale and logistics of a lung cancer screening program. Radiographics 2015;35:18931908.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76.

    Armstrong K, Kim JJ, Halm EA, et al. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer 2016;122:13381342.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77.

    Donnelly EF, Kazerooni EA, Lee E, et al. ACR Appropriateness Criteria Lung Cancer Screening. J Am Coll Radiol 2018;15(11 Suppl):S341346.

  • 78.

    Pinsky PF, Gierada DS, Black W, et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 2015;162:485491.

  • 79.

    Kazerooni EA, Austin JHA, Black WC, et al. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging 2014;29:310316.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 80.

    American College of Radiology. Lung-RADS version 1.1. Accessed June 15, 2022. Available at: https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADSAssessmentCategoriesv1-1.pdf

    • Search Google Scholar
    • Export Citation
  • 81.

    Karush J, Arndt A, Shah P, et al. Improved false-positive rates and the overestimation of unintended harm from lung cancer screening. Lung 2019;197:327332.

  • 82.

    Kaminetzky M, Milch HS, Shmukler A, et al. Effectiveness of Lung-RADS in reducing false-positive results in a diverse, underserved, urban lung cancer screening cohort. J Am Coll Radiol 2019;16:419426.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 83.

    Muñoz-Largacha JA, Steiling KA, Kathuria H, et al. Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital. J Thorac Cardiovasc Surg 2018;155:26742681.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84.

    McKee BJ, Regis SM, McKee AB, et al. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol 2015;12:273276.

  • 85.

    Chelala L, Hossain R, Kazerooni EA, et al. Lung-RADS version 1.1: challenges and a look ahead, from the ajr special series on radiology reporting and data systems. AJR Am J Roentgenol 2021;216:14111422.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 86.

    Hammer MM, Eckel AL, Palazzo LL, et al. Cost-effectiveness of treatment thresholds for subsolid pulmonary nodules in CT lung cancer screening. Radiology 2021;300:586593.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 87.

    Wiener RS, Gould MK, Woloshin S, et al. What do you mean, a spot?: a qualitative analysis of patients’ reactions to discussions with their physicians about pulmonary nodules. Chest 2013;143:672677.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 88.

    Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol 2013;31:10021008.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89.

    Goulart BHL, Ramsey SD. Moving beyond the National Lung Screening Trial: discussing strategies for implementation of lung cancer screening programs. Oncologist 2013;18:941946.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 90.

    Sox HC. Implementing lung cancer screening under Medicare: the last chance to get it right? JAMA 2014;312:12061207.

  • 91.

    Volk RJ, Hawk E, Bevers TB. Should CMS cover lung cancer screening for the fully informed patient? JAMA 2014;312:11931194.

  • 92.

    Field JK, Smith RA, Aberle DR, et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012;7:1019.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 93.

    Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:24182429.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1849 1849 1844
PDF Downloads 1039 1039 1034
EPUB Downloads 0 0 0